LH · 10-Q · 2026Q2 · Full report

End-Market Demand Trends

LABCORP HOLDINGS INC. · 2026-08-05 · Importance 43 · Surprise 32

Labcorp’s total revenue increased 5.8% year over year to $3,731.1 million in the second quarter of 2026, driven by 4.2% organic growth. Diagnostics (Dx) revenue rose 5.5% to $2,900.7 million, with total requisition volume up 3.0% and organic volume up 1.8%; organic price/mix increased 1.8%. Biopharma Laboratory Services (BLS) revenue increased 6.5% to $836.2 million, supported by 6.2% organic growth, while six-month BLS revenue increased 7.3% to $1,616.8 million, including 5.0% organic growth.

Key facts

• Dx total volume, measured by requisitions, increased by 3.0% for the three months ended June 30, 2026, as organic volume increased by 1.8% and acquisition volume, net of divestitures, contributed 1.3%. source
• Dx total volume for the six months ended June 30, 2026, increased by 2.8% as organic volume increased by 1.4% and acquisition volume, net of divestitures, contributed 1.3%. source